12/29/2014 - 10:07am

Actavis and Adamas Pharmaceuticals last week announced that the Food and Drug Administration approved Namzaric. According to the companies, the drug is used to treat moderate to severe dementia of the Alzheimer's type in patients stablized on memantine hydrochloride and donepezil hydrochloride.

 

12/23/2014 - 1:37pm

Unilever’s Axe brand has introduced the new Axe White Label — a refined product line for today’s multi-faceted, sophisticated guy.

12/23/2014 - 11:20am

Duri Cosmetics is launching for spring/summer 2015 a new city-inspired line of nail polish.

12/22/2014 - 2:34pm

Salon Grafix has announced the relaunch of the cult-favorite Professional hair spray.

12/22/2014 - 10:25am

Sandoz has announced the U.S. market introduction of estradiol transdermal system, an authorized generic version of Vivelle-Dot, which is marketed by Novartis Pharmaceuticals.

12/22/2014 - 10:21am

Mylan has announced the U.S. launch of its Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day (twice weekly), which is the generic version of Novartis' Vivelle-DOT.

12/19/2014 - 2:41pm

M.D. Science Lab, manufacturers of Swiss Navy Premium Lubricants, on Thursday unveiled all-new packaging for their brand for mass-market storefronts.

12/19/2014 - 10:33am

India's skincare brand, Clean & Clear, has announced the launch of its new Pimple Clearing Face Wash.

12/19/2014 - 9:23am

Teva Pharmaceutical announced that the Food and Drug Administration approved QNasl (beclomethasone dipropionate) 40 mcg for the treatment of nasal symptoms associated with allergic rhinitis in children ages 4 years to 11 years.